ArticleMolecular therapy. Advances2026

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

Soo Aleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.